Expression	expression	O	O
of	of	O	O
p300	p300	S_chemicals	O
protects	protects	O	O
cardiac	cardiac	O	O
myocytes	myocytes	O	O
from	from	O	O
apoptosis	apoptosis	O	S_disease
in	in	O	O
vivo	vivo	O	O
.	.	O	O

Doxorubicin	doxorubicin	O	O
is	is	O	O
an	an	O	O
anti-tumor	anti-tumor	O	O
agent	agent	O	O
that	that	O	O
represses	represses	O	O
cardiac-specific	cardiac-specific	S_chemicals	O
gene	gene	O	O
expression	expression	O	O
and	and	O	O
induces	induces	O	O
myocardial	myocardial	O	O
cell	cell	O	O
apoptosis	apoptosis	O	S_disease
.	.	O	O

Doxorubicin	doxorubicin	O	O
depletes	depletes	O	O
cardiac	cardiac	O	O
p300	p300	S_chemicals	O
,	,	O	O
a	a	O	O
transcriptional	transcriptional	S_chemicals	O
coactivator	coactivator	S_chemicals	O
that	that	O	O
is	is	O	O
required	required	O	O
for	for	O	O
the	the	O	O
maintenance	maintenance	O	O
of	of	O	O
the	the	O	O
differentiated	differentiated	O	O
phenotype	phenotype	O	O
of	of	O	O
cardiac	cardiac	O	O
myocytes	myocytes	O	O
.	.	O	O

However	however	O	O
,	,	O	O
the	the	O	O
role	role	O	O
of	of	O	O
p300	p300	S_chemicals	O
in	in	O	O
protection	protection	O	O
against	against	O	O
doxorubicin-induced	doxorubicin-induced	O	O
apoptosis	apoptosis	O	S_disease
is	is	O	O
unknown	unknown	O	O
.	.	O	O

Transgenic	transgenic	O	O
mice	mice	O	O
overexpressing	overexpressing	O	O
p300	p300	S_chemicals	O
in	in	O	O
the	the	O	O
heart	heart	O	O
and	and	O	O
wild-type	wild-type	O	O
mice	mice	O	O
were	were	O	O
subjected	subjected	O	O
to	to	O	O
doxorubicin	doxorubicin	O	O
treatment	treatment	O	O
.	.	O	O

Compared	compared	O	O
with	with	O	O
wild-type	wild-type	O	O
mice	mice	O	O
,	,	O	O
transgenic	transgenic	O	O
mice	mice	O	O
exhibited	exhibited	O	O
higher	higher	O	O
survival	survival	O	O
rate	rate	O	O
as	as	O	O
well	well	O	O
as	as	O	O
more	more	O	O
preserved	preserved	O	O
left	left	O	B_disease
ventricular	ventricular	O	I_disease
function	function	O	O
and	and	O	O
cardiac	cardiac	O	O
expression	expression	O	O
of	of	O	O
alpha-sarcomeric	alpha-sarcomeric	O	O
actin	actin	S_chemicals	O
.	.	O	O

Doxorubicin	doxorubicin	O	O
induced	induced	O	O
myocardial	myocardial	O	O
cell	cell	O	O
apoptosis	apoptosis	O	S_disease
in	in	O	O
wild-type	wild-type	O	O
mice	mice	O	O
but	but	O	O
not	not	O	O
in	in	O	O
transgenic	transgenic	O	O
mice	mice	O	O
.	.	O	O

Expression	expression	O	O
of	of	O	O
p300	p300	S_chemicals	O
increased	increased	O	O
the	the	O	O
cardiac	cardiac	O	O
level	level	O	O
of	of	O	O
bcl-2	bcl-2	S_chemicals	O
and	and	O	O
mdm-2	mdm-2	O	O
,	,	O	O
but	but	O	O
not	not	O	O
that	that	O	O
of	of	O	O
p53	p53	O	O
or	or	O	O
other	other	O	O
members	members	O	O
of	of	O	O
the	the	O	O
bcl-2	bcl-2	S_chemicals	O
family	family	O	O
.	.	O	O

These	these	O	O
findings	findings	O	O
demonstrate	demonstrate	O	O
that	that	O	O
overexpression	overexpression	O	O
of	of	O	O
p300	p300	S_chemicals	O
protects	protects	O	O
cardiac	cardiac	O	O
myocytes	myocytes	O	O
from	from	O	O
doxorubicin-induced	doxorubicin-induced	O	O
apoptosis	apoptosis	O	S_disease
and	and	O	O
reduces	reduces	O	O
the	the	O	O
extent	extent	O	O
of	of	O	O
acute	acute	O	O
heart	heart	O	B_disease
failure	failure	O	I_disease
in	in	O	O
adult	adult	O	O
mice	mice	O	O
in	in	O	O
vivo	vivo	O	O
.	.	O	O

